Tag: Hot flashes

According to research, more than 22% of adults in the U.S. who take antidepressants experience excessive sweating, a common symptom associated with hot flashes. While most people associate hot flashes with menopause, many different **medications can cause hot flashes** as an unintended side effect, disrupting the body's natural temperature regulation. This article will explore the various drug classes that can trigger these uncomfortable episodes and explain the physiological mechanisms at play.

Approximately 75% of women experience hot flashes during menopause, with up to 25% reporting severe symptoms that disrupt daily life. For those seeking alternatives to hormone therapy, understanding what is the best antidepressant for hot flashes requires considering several effective non-hormonal options, including SSRIs and SNRIs.

Up to 80% of menopausal women experience vasomotor symptoms (VMS), such as hot flashes. For those exploring non-hormonal options, a primary concern is: **how long does it take Paxil to work for hot flashes?** This article examines the expected timeline for relief.

On May 12, 2023, the U.S. Food and Drug Administration (FDA) approved Veozah (fezolinetant) as a new prescription medication. This landmark decision provided a non-hormonal treatment option for women experiencing moderate to severe vasomotor symptoms (VMS), also known as hot flashes, due to menopause.

Over 70% of women experience hot flashes and night sweats during menopause. So, **does Paxil help with hot flashes?** Yes, a low-dose formulation of paroxetine, the active ingredient in Paxil, is an FDA-approved non-hormonal treatment shown to significantly reduce the frequency and severity of these vasomotor symptoms.

Affecting up to 80% of menopausal women, hot flashes can disrupt daily life and sleep. For those considering non-hormonal treatment, understanding **how quickly does Veozah take effect** is key to managing expectations and evaluating its efficacy in managing moderate to severe vasomotor symptoms.

More than 60 drugs are known to have major interactions with Veozah (fezolinetant), making it critically important to know **what meds are contraindicated with veozah** before starting treatment. The primary concern involves medications that inhibit the CYP1A2 enzyme, which can cause Veozah to build up to dangerous levels and increase the risk of serious side effects, including liver injury.

In clinical trials, up to 36% of postmenopausal women taking anastrozole for early-stage breast cancer reported experiencing hot flashes and muscle or joint problems. Anastrozole, also known by the brand name Arimidex, is an aromatase inhibitor prescribed to block estrogen production, a process that can lead to various side effects. Patients must be aware of the most common side effects of anastrozole to effectively manage their treatment.

Diltiazem, a calcium channel blocker used to treat cardiovascular conditions, can cause common side effects like flushing or a feeling of warmth, which some people experience as hot flashes. This reaction is a result of the medication's vasodilating properties that widen blood vessels.

In December 2024, the U.S. Food and Drug Administration (FDA) added a Boxed Warning to the prescribing information for Veozah (fezolinetant) regarding the risk of serious liver injury. This warning was issued after a postmarketing case highlighted a rare but potentially serious hepatotoxicity event. It is crucial for patients and healthcare providers to understand that **does veozah cause liver problems** in rare instances, necessitating careful monitoring.